- Lung Cancer Basics
$10.5 million funding for Department of Defense Lung Cancer Research Program Included Despite Threats of Sequestration
WASHINGTON, DC [Thursday, March 21, 2013]—Today, Lung Cancer Alliance (LCA) commends the US Congress on the passage of a Continuing Resolution for the remainder of FY2013 that includes $10.5 million in funding for the Department of Defense (DOD) Lung Cancer Research Program. This would bring the total funding so far for this program, which was established in 2009, to nearly $70 million.
Through the efforts of Lung Cancer Alliance, the Lung Cancer Research Program (LCRP) was established within the Department of Defense (DOD) Congressionally Directed Medical Research Program (CDMRP) and allocated an initial $20 million to fund early detection research targeting at-risk military.
"With the specter of sequestration hanging over so many important programs, continued funding for the lung cancer screening program and all other programs within the CDMRP is deeply gratifying," stated Lung Cancer Alliance President and CEO, Laurie Fenton Ambrose.
“Securing increased federal research funding for all aspects of lung cancer has been, and will continue to be, a core priority of our organization,” Fenton Ambrose added. “And we remain grateful to congressional leaders for their continued backing of this specific and important program.”
Lung cancer is the leading cause of cancer death among men and women and every ethnic group—taking more lives each year than breast, prostate, colon and pancreatic cancers combined.
Without screening, the majority of lung cancers are diagnosed at such a late stage that the five year survival rate is only 15%—virtually unchanged since the 1971 declaration of “War on Cancer.”